首页> 外文期刊>Journal of cardiology >Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction
【24h】

Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction

机译:混合型溶栓联合备用经皮腔内冠状动脉成形术在急性心肌梗死患者中的联合应用

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: Conventional thrombolytic therapy for acute myocardial infarction is effective for early reperfusion but has the disadvantage of a higher rate of bleeding complications. The purpose of this study is to elucidate efficacy and safety of a combined approach using a bolus injection of low dose of mutant tissue plasminogen activator (mt-PA) with heparin and aspirin to ensure definite antithrombin and antiplatelet efficacy, followed by back-up percutaneous transluminal coronary angioplasty(PTCA). METHODS: Patients with acute myocardial infarction aged < 80 years who were admitted to our institution within 3 hr of onset of symptoms were immediately treated with oral aspirin 330 mg and intravenous heparin 5,000 IU and were randomized to receive an intravenous bolus of mt-PA (monteplase) 15,000 IU/kg (thrombolytic group, n = 25) or no mt-PA (control group, n = 21), followed by angiography with PTCA if indicated. RESULTS: There were no differences between the two groups in patient characteristics, time from onset to hospital arrival, time to initial angiography, or infarct-related arteries. Significantly more patients had Thrombolysis in Myocardial Infarction flow grade 3 and grade 2/3 at the initial angiography in the thrombolytic group than in the control group (32.0% vs 4.8%, 68.0% vs 14.3%; p = 0.020, p = 0.0003, respectively). PTCA was performed in 88% of the thrombolytic group (stenting employed in 64%) and 95.5% of the control group (stenting in 57%), and the success rate was 95.5% and 100%, respectively. No acute or subacute coronary occlusion was found in either group. Bleeding complications occurred in only one patient in the thrombolytic group, which was bleeding associated with vomiting, and no difference was found in other complications between the two groups. Radionuclide ventriculography using quantitative gated single photon emission computed tomography showed left ventricular end-diastolic volume and left ventricular end-systolic volume tended to be smaller, and the ejection fraction after 3 months of treatment tended to be higher in the thrombolytic group. Myocardial salvage volume was significantly higher in the thrombolytic group. CONCLUSIONS: Hybrid thrombolysis using a low dose of mt-PA with aspirin and heparin promoted significantly early reperfusion. Also, successful reperfusion is achievable at higher rates with back-up PTCA without an increase in complications.
机译:目的:常规的溶栓治疗急性心肌梗塞对早期再灌注有效,但缺点是出血并发症发生率更高。这项研究的目的是阐明使用大剂量低剂量突变体纤溶酶原激活剂(mt-PA)与肝素和阿司匹林的推注,以确保确定的抗凝血酶和抗血小板药效,然后经皮备用的联合方法的功效和安全性腔内冠状动脉成形术(PTCA)。方法:在症状发作后3小时内入院的80岁以下急性心肌梗死患者应立即接受口服阿司匹林330 mg和静脉肝素5,000 IU的治疗,并随机接受静脉推注mt-PA(莫替普酶)15,000 IU / kg(溶栓组,n = 25)或无mt-PA(对照组,n = 21),然后根据需要进行PTCA血管造影。结果:两组患者的特征,从发病到到达医院的时间,到初次血管造影的时间或与梗塞相关的动脉没有差异。溶栓治疗组在初次血管造影时发生心肌梗塞的3级和2/3级溶栓患者明显多于对照组(32.0%vs. 4.8%,68.0%vs 14.3%; p = 0.020,p = 0.0003,分别)。 PTCA分别在溶栓组的88%(采用支架的占64%)和对照组的95.5%(支架的占57%​​)中进行,成功率分别为95.5%和100%。两组均未发现急性或亚急性冠状动脉阻塞。溶栓组中只有1例发生了出血并发症,这是与呕吐相关的出血,两组之间在其他并发症上没有发现差异。溶栓组中使用定量门控单光子发射计算机断层扫描的放射性核素心室造影显示左心室舒张末期容积和左心室收缩末期容积较小,治疗3个月后的射血分数倾向于较高。溶栓组的心肌抢救量明显更高。结论:低剂量的mt-PA与阿司匹林和肝素的混合溶栓可显着促进早期再灌注。同样,使用备用PTCA可以更高的成功率实现再灌注,而不会增加并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号